ALRM vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

ALRM

53.9
AI Score
VS
ALRM Wins

DBD

45.7
AI Score

Investment Advisor Scores

ALRM

54score
Recommendation
HOLD

DBD

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ALRM DBD Winner
Revenue 542.93M 1.82B DBD
Net Income 47.59M 20.50M ALRM
Net Margin 8.8% 1.1% ALRM
Operating Income 64.13M 90.00M DBD
ROE 5.5% 2.1% ALRM
ROA 2.9% 0.5% ALRM
Total Assets 1.66B 3.74B DBD
Current Ratio 4.96 1.27 ALRM

Relative Price Performance (Last 90 Days)

ALRM 1M: -0.2% · 3M: +19.3% DBD 1M: -8.6% · 3M: -19.6%

Current Technical Phase

ALRM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.8 · Price: $55.36

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.1%), weak momentum, RSI 35

RSI (14): 34.5 · Price: $65.62

Fundamentals Snapshot

Metric ALRM DBD
Market Cap
Forward P/E 18.0 9.4
Trailing P/E 24.4 22.1
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin 0.2% 0.1%
EPS 2.26 2.96
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ALRM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.